Nurix Therapeutics, Inc. NRIX Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s contract liabilities, non-current?
- Nurix Therapeutics, Inc. (NRIX) reported contract liabilities, non-current of $7.59M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s contract liabilities, non-current changed year-over-year?
- Nurix Therapeutics, Inc.'s contract liabilities, non-current decreased by 68.6% year-over-year, from $24.15M to $7.59M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s contract liabilities, non-current?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s contract liabilities, non-current has grown at a -30.3% compound annual growth rate (CAGR), from $60.69M to $10.01M.